229 related articles for article (PubMed ID: 23105966)
1. Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach.
Klein G; Gold LS; Sullivan SD; Buist DS; Ramsey S; Kreizenbeck K; Snell K; Loggers ET; Gifford J; Watkins JB; Kessler L
J Comp Eff Res; 2012 May; 1(3):241-55. PubMed ID: 23105966
[TBL] [Abstract][Full Text] [Related]
2. Identification of topics for comparative effectiveness systematic reviews in the field of cancer imaging.
Rao M; Concannon TW; Iovin R; Yu WW; Chan JA; Lypas G; Terasawa T; Gaylor JM; Kong L; Rausch AC; Lau J; Kitsios GD
J Comp Eff Res; 2013 Sep; 2(5):483-95. PubMed ID: 24236745
[TBL] [Abstract][Full Text] [Related]
3. Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.
Krishnan JA; Lindenauer PK; Au DH; Carson SS; Lee TA; McBurnie MA; Naureckas ET; Vollmer WM; Mularski RA;
Am J Respir Crit Care Med; 2013 Feb; 187(3):320-6. PubMed ID: 23155144
[TBL] [Abstract][Full Text] [Related]
4. Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.
Esmail LC; Roth J; Rangarao S; Carlson JJ; Thariani R; Ramsey SD; Veenstra DL; Deverka P
Genet Med; 2013 Feb; 15(2):115-22. PubMed ID: 23037935
[TBL] [Abstract][Full Text] [Related]
5. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
[TBL] [Abstract][Full Text] [Related]
6. Prioritization in comparative effectiveness research: the CANCERGEN Experience.
Thariani R; Wong W; Carlson JJ; Garrison L; Ramsey S; Deverka PA; Esmail L; Rangarao S; Hoban CJ; Baker LH; Veenstra DL;
Med Care; 2012 May; 50(5):388-93. PubMed ID: 22274803
[TBL] [Abstract][Full Text] [Related]
7. A lung cancer research agenda that reflects the diverse perspectives of community stakeholders: process and outcomes of the SEED method.
Rafie CL; Zimmerman EB; Moser DE; Cook S; Zarghami F
Res Involv Engagem; 2019; 5():3. PubMed ID: 30656063
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD.
Bell-Brown A; Watabayashi K; Kreizenbeck K; Ramsey SD; Bansal A; Barlow WE; Lyman GH; Hershman DL; Mercurio AM; Segarra-Vazquez B; Kurttila F; Myers JS; Golenski JD; Johnson J; Erwin RL; Walia G; Crawford J; Sullivan SD
J Comp Eff Res; 2022 Dec; 11(18):1313-1321. PubMed ID: 36378570
[No Abstract] [Full Text] [Related]
9. Stakeholder engagement in eight comparative effectiveness trials in African Americans and Latinos with asthma.
Dy T; Hamilton WJ; Kramer CB; Apter A; Krishnan JA; Stout JW; Teach SJ; Federman A; Elder J; Bryant-Stephens T; Bruhl RJ; Jackson S; Sumino K
Res Involv Engagem; 2022 Nov; 8(1):63. PubMed ID: 36434672
[TBL] [Abstract][Full Text] [Related]
10. A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.
Holve E; Lopez MH; Scott L; Segal C
J Comp Eff Res; 2012 Sep; 1(5):441-51. PubMed ID: 24236421
[TBL] [Abstract][Full Text] [Related]
11. Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement.
Deverka PA; Lavallee DC; Desai PJ; Esmail LC; Ramsey SD; Veenstra DL; Tunis SR
J Comp Eff Res; 2012 Mar; 1(2):181-194. PubMed ID: 22707880
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Comparative Effectiveness Research Priorities for Care Coordination in Chronic Obstructive Pulmonary Disease: A Community-Based eDelphi Study.
Stellefson M; Alber J; Paige S; Castro D; Singh B
JMIR Res Protoc; 2015 Aug; 4(3):e103. PubMed ID: 26268741
[TBL] [Abstract][Full Text] [Related]
13. Incorporating stakeholder perspectives in developing a translation table framework for comparative effectiveness research.
Gliklich RE; Leavy MB; Velentgas P; Dreyer NA; Tunis SR; Mohr P; Messner DA; Moloney RM; Karkare SU; Dubois RW; Graff JS
J Comp Eff Res; 2012 May; 1(3):281-92. PubMed ID: 24237409
[TBL] [Abstract][Full Text] [Related]
14. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium.
Greenberg CC; Wind JK; Chang GJ; Chen RC; Schrag D
J Comp Eff Res; 2013 Mar; 2(2):117-25. PubMed ID: 24236554
[TBL] [Abstract][Full Text] [Related]
15. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
[TBL] [Abstract][Full Text] [Related]
16. Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned.
Forsythe LP; Ellis LE; Edmundson L; Sabharwal R; Rein A; Konopka K; Frank L
J Gen Intern Med; 2016 Jan; 31(1):13-21. PubMed ID: 26160480
[TBL] [Abstract][Full Text] [Related]
17. Setting research priorities in tobacco control: a stakeholder engagement project.
Lindson N; Richards-Doran D; Heath L; Hartmann-Boyce J;
Addiction; 2017 Dec; 112(12):2257-2271. PubMed ID: 28879662
[TBL] [Abstract][Full Text] [Related]
18. Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.
Pickard AS; Lee TA; Solem CT; Joo MJ; Schumock GT; Krishnan JA
Clin Pharmacol Ther; 2011 Dec; 90(6):888-92. PubMed ID: 22048220
[TBL] [Abstract][Full Text] [Related]
19. The ARRA investment in CER: a description of the midstream evaluation and how the funds were allocated and CER priorities addressed.
Esposito D; Yong PL; Rich E; Geonnotti K; Kimmey LD
J Comp Eff Res; 2014 Nov; 3(6):581-9. PubMed ID: 25494564
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
